Back
BioNTech SE 10K Form
Sell
29
BNTX
BioNTech SE
Last Price:
$96.20
Seasonality Move:
1.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNTX News And Ratings
See the #1 stock for the next 7 days that we like better than BNTX
BNTX Financial Statistics
Sales & Book Value
| Annual Sales: | $3B |
|---|---|
| Cash Flow: | $-605.5M |
| Price / Cash Flow: | 25.47 |
| Annual Sales: | $84.17 |
| Price / Book: | 1.18 |
Profitability
| EPS (TTM): | -2.99870 |
|---|---|
| Net Income (TTM): | $-717.6M |
| Gross Margin: | $2.4B |
| Return on Equity: | -3.39% |
| Return on Assets: | -2.95% |
BioNTech SE Earnings Forecast
Key BioNTech SE Financial Ratios
-
The Gross Profit Margin over the past 8 years for BNTX is 80.32%.
-
The Selling, General & Administrative Expenses for BNTX have been equal to 21.77% of Gross Profit Margin.
-
The Research & Development expenses have been 81.94% of Revenue.
-
The Net Earning history of BNTX is -24.18% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
BioNTech SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNTX |
| CUSIP: | 09075V |
| Website: | biontech.de |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 7.45 |
| Quick Ratio: | 7.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.23 |
|---|---|
| Forward P/E Ratio: | 0 |
BNTX Technical Analysis vs Fundamental Analysis
Sell
29
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a SellThe current BioNTech SE [BNTX] share price is $99.27. The Score for BNTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.